Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 4.


Al-Jameel, W, Gou, X, Jin, X, Zhang, J, Wei, Q, Ai, J, Li, H, Al-Bayati, A, Platt-Higgins, A, Pettitt, A
et al (show 2 more authors) (2019) Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPARγ. Genes and Cancer, 10 (3-4). 80 - 96.


Al-Jameel, W, Gou, X, Jin, X, Zhang, J, Wei, Q, Ai, J, Li, H, Al-Bayati, A, Platt-Higgins, A, Pettitt, A
et al (show 2 more authors) (2019) Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPARγ. Genes and Cancer, 10 (3-4). 80 - 96.


AL Fayi, MS, Gou, X, Forootan, S, Al-Jameel, W, Zhang, J, Bao, Z, Rudland, PS ORCID: 0000-0002-7491-0846, Conford, P, Hussain, S and Ke, Y ORCID: 0000-0001-5341-8644
(2016) Increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance. Oncotarget, 7 (50). 82783 - 82797.


Al-Jameel, W, Gou, X, Forootan, SS, Al Fayi, MS, Rudland, PS ORCID: 0000-0002-7491-0846, Forootan, FS, Zhang, J, Cornford, PA, Hussain, SA and Ke, Y ORCID: 0000-0001-5341-8644
(2017) Inhibitor SBFI26 suppresses castration-resistant prostate cancer by competitively binding to oncogenic FABP5. Oncotarget.

This list was generated on Sun Dec 8 04:18:08 2019 GMT.